BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11837451)

  • 1. Agouti: from mouse to man, from skin to fat.
    Voisey J; van Daal A
    Pigment Cell Res; 2002 Feb; 15(1):10-8. PubMed ID: 11837451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The melanocortin-1 receptor and human pigmentation.
    Abdel-Malek Z; Suzuki I; Tada A; Im S; Akcali C
    Ann N Y Acad Sci; 1999 Oct; 885():117-33. PubMed ID: 10816645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation.
    Cone RD; Lu D; Koppula S; Vage DI; Klungland H; Boston B; Chen W; Orth DN; Pouton C; Kesterson RA
    Recent Prog Horm Res; 1996; 51():287-317; discussion 318. PubMed ID: 8701084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo.
    Ollmann MM; Lamoreux ML; Wilson BD; Barsh GS
    Genes Dev; 1998 Feb; 12(3):316-30. PubMed ID: 9450927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of yellow pigment formation in mice: a historical perspective.
    Wolff GL
    Pigment Cell Res; 2003 Feb; 16(1):2-15. PubMed ID: 12519120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the agouti gene in the yellow obese syndrome.
    Miltenberger RJ; Mynatt RL; Wilkinson JE; Woychik RP
    J Nutr; 1997 Sep; 127(9):1902S-1907S. PubMed ID: 9278579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival.
    Kadekaro AL; Kanto H; Kavanagh R; Abdel-Malek Z
    Ann N Y Acad Sci; 2003 Jun; 994():359-65. PubMed ID: 12851336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor.
    Lu D; Willard D; Patel IR; Kadwell S; Overton L; Kost T; Luther M; Chen W; Woychik RP; Wilkison WO
    Nature; 1994 Oct; 371(6500):799-802. PubMed ID: 7935841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic studies of the mouse mutations mahogany and mahoganoid.
    Miller KA; Gunn TM; Carrasquillo MM; Lamoreux ML; Galbraith DB; Barsh GS
    Genetics; 1997 Aug; 146(4):1407-15. PubMed ID: 9258683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.
    Suzuki I; Tada A; Ollmann MM; Barsh GS; Im S; Lamoreux ML; Hearing VJ; Nordlund JJ; Abdel-Malek ZA
    J Invest Dermatol; 1997 Jun; 108(6):838-42. PubMed ID: 9182807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agouti signal protein regulation in human melanoma cells.
    Voisey J; Kelly G; Van Daal A
    Pigment Cell Res; 2003 Feb; 16(1):65-71. PubMed ID: 12519127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
    Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD
    Nature; 1997 Jan; 385(6612):165-8. PubMed ID: 8990120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocortin receptors and antagonists regulate pigmentation and body weight.
    Jordan SA; Jackson IJ
    Bioessays; 1998 Aug; 20(8):603-6. PubMed ID: 9780833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
    Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
    Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice.
    Miltenberger RJ; Mynatt RL; Bruce BD; Wilkison WO; Woychik RP; Michaud EJ
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8579-84. PubMed ID: 10411918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The yellow mouse obesity syndrome and mechanisms of agouti-induced obesity.
    Moussa NM; Claycombe KJ
    Obes Res; 1999 Sep; 7(5):506-14. PubMed ID: 10509609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessory proteins for melanocortin signaling: attractin and mahogunin.
    He L; Eldridge AG; Jackson PK; Gunn TM; Barsh GS
    Ann N Y Acad Sci; 2003 Jun; 994():288-98. PubMed ID: 12851328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
    Mountjoy KG; Willard DH; Wilkison WO
    Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Agouti-related protein binding to melanocortin receptors.
    Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
    Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of leptin by agouti.
    Claycombe KJ; Xue BZ; Mynatt RL; Zemel MB; Moustaid-Moussa N
    Physiol Genomics; 2000 Apr; 2(3):101-5. PubMed ID: 11015588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.